Author:
Riemsma Rob,Forbes C. A.,Kessels A.,Lykopoulos K.,Amonkar M. M.,Rea D. W.,Kleijnen J.
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Cancer Research UK (2009) CancerStats key facts on breast cancer. http://info.cancerresearchuk.org/cancerstats/types/breast/incidence/?a=5441 . Accessed 25 Aug 2009
2. Cancer Research UK (2009) UK breast cancer mortality statistics. http://info.cancerresearchuk.org/cancerstats/types/breast/mortality/?a=5441 . Accessed 25 Aug 2009
3. National Institute for Health and Clinical Excellence (2009) Draft scope for the appraisal of lapatinib for the first-line treatment of metastatic hormone sensitive breast cancer (Issue Date April 2009), 25 June 2009
4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717
5. Gibson LJ, Dawson CK, Lawrence DH, Bliss JM (2007) Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Cochrane Database Syst Rev (1):CD003370
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献